pylori eradication, expanding GI treatment scope CG MedTech completes smart office, expands implant production capacity Daewoong, FMI invest in General Proximity to advance induced-proximity drugs Dong-A University Hospital rolls out regions largest AI smart ward with Daewoong Daewoong, Puzzle AI partner to launch AI medical record platform CL Note Daewoongs Fexuclue wins Indonesia nod, expands into Southeast Asia P-CAB market MetaVias obesity drug candidate DA-1726 to be presented at European liver meeting Daewoong takes over US anti-aging platform in $239 mil-linked deal Beyond weight loss: Korean drugmakers to showcase obesity innovation at ADA 2026 Kim Ji-hye [email protected]
IGF-1 LR3 contains a 13-amino-acid N-terminal extension and glutamic acid substitution at position 3, which reduces binding affinity to IGF-binding proteins (IGFBPs) by approximately 100-fold while maintaining full IGF-1 receptor binding capacity
Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities
1517 The present results highlight the renoprotective effects of semaglutide in obese mice based on metabolomics
This is rarely dangerous on its own, but it is worth disclosing to your provider
Il est important de savoir que la production de Glutathion par notre corps diminue ds la cinquantaine